Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κb-p65 and cyclooxygenase-2

Molecular Medicine Reports

Volumn 13, Issue 2, 2016, Pages 1263-1268

  Su, Chin Cheng ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AGS gastric carcinoma cells; Matrix metalloproteinases; Migration; Nuclear factor B p65; Tanshinone IIA

Indexed keywords

BETA ACTIN; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; MATRILYSIN; TANSHINONE IIA; TRANSCRIPTION FACTOR RELA; ABIETANE DERIVATIVE; ACTIN; ANTINEOPLASTIC AGENT; DAN-SHEN ROOT EXTRACT; HERBACEOUS AGENT; MMP7 PROTEIN, HUMAN; RELA PROTEIN, HUMAN; TANSHINONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WOUND HEALING; APOPTOSIS; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ACTINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE 2; DITERPENES, ABIETANE; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR RELA;

EID: 84956933919     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4658     Document Type: Article

References (22)

1. Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD and Chen XG: Separation and determination of active components in Radix Salviae miltiorrhizae and its medicinal preparations by nonaqueous capillary electrophoresis. J Sep Sci 27: 569-575, 2004.
2. Zhou L, Zuo Z and Chow MS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-1359, 2005.
3. Chiu TL and Su CC: Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 25: 231-236, 2010.
4. Su CC and Lin YH: Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 22: 357-361, 2008.
5. Yan MY, Chien SY, Kuo SJ, Chen DR and Su CC: Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression. Int J Mol Med 29: 855-863, 2012.
6. Cheng CY and Su CC: Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression. Int J Mol Med 26 :379-385, 2010.
7. Huang CY, Chiu TL, Kuo SJ, Chien SY, Chen DR and Su CC: Tanshinone IIA inhibits the growth of pancreatic cancer BxPC 3 cells by decreasing protein expression of TCTP, MCL 1 and Bcl-xL. Mol Med Rep 7: 1045-1049, 2013.
8. Su CC, Chen GW, Kang JC and Chan MH: Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med 74: 1357-1362, 2008.
9. Su CC: Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl 1 and Bcl-xL and increasing Bax and CHOP protein expression. Int J Mol Med. 34: 1661-1668, 2014.
10. Su CC: Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res 34: 7097-7110, 2014.
11. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466, 2004.
12. Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP, Shun CT, Chen GH, Huang SP and Lin JT: Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 43: 799-808, 2007.
13. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
14. Elnemr A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Tochiori S, Endou Y and Sasaki T: Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 6: 30-38, 2003.
15. Xu M, Cao FL, Li NY, Liu YQ, Li YP and Lv CL: Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells. Asian Pac J Cancer Prev 14: 173-177, 2013.
16. Rodriguez LG, Wu X and Guan JL: Wound-healing assay. Methods Mol Biol 294: 23-29, 2005.
17. Shen W, Xi H, Wei B and Chen L: The prognostic role of matrix metalloproteinase 2 in gastric cancer: A systematic review with meta-analysis. J Cancer Res Clin Oncol 40: 1003-1009, 2014.
18. de la Peña S, Sampieri CL, Ochoa-Lara M, León-Córdoba K and Remes-Troche JM: Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis Markers 2014: 285906, 2014.
19. Wang HL, Zhou PY, Zhang Y and Liu P: Relationships between abnormal MMP2 expression and prognosis in gastric cancer: A meta-analysis of cohort studies. Cancer Biother Radiopharm 29: 166-172, 2014.
20. Yang TF, Guo L and Wang Q: Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk. Asian Pac J Cancer Prev 15: 1263-1267, 2014.
21. Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, Han J, Lin Y, Xie Y, Xie F, et al: IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer 31: 13-18, 2014.
22. Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H and Wang Y: Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway. Mol Med Rep 11: 1366-1371, 2015.